Tatva Chintan Pharma Chem Ltd Nine Monthly Results

Gross Sales

274.85

295.24

299.1

335.12

191.69

Excise Duty

0

0

0

0

0

Net Sales

274.85

295.24

299.1

335.12

191.69

Other Operating Income

0

0

0

0

0

Other Income

1.21

2.98

4.9

9.29

3.34

Total Income

276.06

298.22

304

344.41

195.03

Total Expenditure

249.2

242.65

254.8

249.58

150.46

PBIDT

26.86

55.57

49.2

94.83

44.58

Interest

0.9

6.32

5.21

3.65

3.16

PBDT

25.95

49.25

44

91.18

41.41

Depreciation

20.4

19.37

7.02

6.03

4.96

Minority Interest Before NP

0

0

0

0

0

Tax

0.88

5.47

7.23

15.09

6.5

Deferred Tax

-0.01

3.67

1.21

-8.31

-1.18

Reported Profit After Tax

4.68

20.74

28.53

78.36

31.14

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

4.68

20.74

28.53

78.36

31.14

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

4.68

20.74

28.53

78.36

31.14

EPS (Unit Curr.)

2

9.13

12.87

36.82

15.5

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

23.39

23.39

22.17

22.17

8.04

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

9.77

18.82

16.44

28.29

23.25

PBDTM(%)

9.44

16.68

14.71

27.2

21.6

PATM(%)

1.7

7.02

9.53

23.38

16.24